Cronos (CRON) Net Income Growth (1y) (2020 - 2026)

Cronos (CRON) Net Income Growth (1y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Haleon 89.86 Bn 88.00 Bn - -
2 Teva Pharmaceutical Industries 35.96 Bn 32.22 Bn 1.97 Bn 68.18%
3 Zoetis 32.55 Bn 30.61 Bn 1.62 Bn -0.17%
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -384.49%
5 United Therapeutics 23.05 Bn 20.90 Bn 648.10 Mn -14.68%
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 105.80%
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn 2,405.06%
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn -14.93%
10 Cronos 1.08 Bn 257.46 Mn 19.15 Mn 103.43%

Historic Data

Download Data
DateValue
Mar 31, 2026 103.43%
Dec 31, 2023 104.63%
Sep 30, 2023 95.19%
Jun 30, 2023 -0.82%
Dec 31, 2022 99.00%
Sep 30, 2022 -4,710.98%
Jun 30, 2022 -401.07%
Dec 31, 2021 -204,957.25%
Sep 30, 2021 117.34%
Jun 30, 2021 -1,119.57%
Dec 31, 2020 56.33%
Sep 30, 2020 -1,213.89%
Jun 30, 2020 -100.02%